Celltrion
068270.KS
#786
Rank
NZ$43.72 B
Marketcap
$211.67
Share price
-0.12%
Change (1 day)
-4.19%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.92

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $5.12. In 2022 the company made an earnings per share (EPS) of $4.99 a decrease over its 2021 EPS that were of $5.92.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.92-1.34%
2022$4.99-15.84%
2021$5.9212.77%
2020$5.2570.79%
2019$3.0815.63%
2018$2.66-33.13%
2017$3.98141.17%
2016$1.658.28%
2015$1.5211.28%
2014$1.3716.37%
2013$1.18-67.42%
2012$3.6184.22%
2011$1.9662.13%
2010$1.2180.61%
2009$0.67-559.63%
2008-$0.15-123.16%
2007$0.63